Daewoong Pharmaceutical Co., Ltd (KRX: 069620)
South Korea
· Delayed Price · Currency is KRW
127,500
-3,500 (-2.67%)
Nov 18, 2024, 3:30 PM KST
Daewoong Pharmaceutical Revenue
Daewoong Pharmaceutical had revenue of 360.54B KRW in the quarter ending June 30, 2024, with 2.96% growth. This brings the company's revenue in the last twelve months to 1.40T, up 5.01% year-over-year. In the year 2023, Daewoong Pharmaceutical had annual revenue of 1.38T with 7.44% growth.
Revenue (ttm)
1,399.05B
Revenue Growth
+5.01%
P/S Ratio
1.05
Revenue / Employee
818.16M
Employees
1,710
Market Cap
1,467.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,375.33B | 95.24B | 7.44% |
Dec 31, 2022 | 1,280.09B | 127.12B | 11.03% |
Dec 31, 2021 | 1,152.98B | 97.55B | 9.24% |
Dec 31, 2020 | 1,055.42B | -58.00B | -5.21% |
Dec 31, 2019 | 1,113.43B | 82.00B | 7.95% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition